ST2 IN REJECTION OF THE TRANSPLANTED HEART

被引:0
|
作者
Shevchenko, O. P. [1 ,2 ]
Ulybysheva, A. A. [1 ,3 ]
Velikiy, D. A. [1 ]
Shevchenko, A. O. [1 ,3 ]
机构
[1] Minist Healthcare Russian Federat, VI Shumakov Fed Res Ctr Transplantol & Artificial, Moscow, Russia
[2] IM Sechenov First Moscow State Med Univ, VI Shumakov Fed Res Ctr Transplantol & Artificial, Moscow, Russia
[3] NI Pirogov Russian Natl Res Med Univ, Moscow, Russia
来源
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV | 2015年 / 17卷 / 04期
关键词
heart transplantation; ST2; heart failure; rejection;
D O I
10.15825/1995-1191-2015-4-90-94
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
This review summarizes the current literature devoted to the analysis of prognostic role of ST2 biomarker in rejection of the transplanted heart. ST2 is one of the most promising diagnostic markers of the development and severity of heart failure as well as the mortality risk in patients with cardiovascular diseases. ST2 is expressed in cardiomyocytes in response to a variety of pathological processes and mechanical damage to the heart, which allows diagnosing cardiovascular diseases before clinical manifestations. Presumably, measuring the level of ST2 in heart transplant may have diagnostic and prognostic value in the assessment of graft and risk of rejection. Currently, accumulated clinical data on the role of given biomarker in heart transplantation are not enough, and further research on the relation of ST2 levels with different clinical and laboratory parameters in heart recipients is necessary.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 50 条
  • [31] HYPERACUTE REJECTION OF THE TRANSPLANTED MOUSE HEART
    HISATAKE, G
    HAMMOND, E
    IVES, M
    GRIFFITH, J
    SHELBY, J
    EICHWALD, EJ
    TRANSPLANTATION, 1989, 47 (06) : 996 - 1000
  • [32] ST2 pathophysiological profile in ambulatory heart failure patients
    Lupon, J.
    De Antonio, M.
    Galan, A.
    Zamora, E.
    Domingo, M.
    Urrutia, A.
    Cabanes, R.
    Altimir, S.
    Diez, C.
    Bayes-Genis, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 280 - 280
  • [33] EFFECTIVENESS OF THE ST2 FOR PROGNOSIS IN HEART FAILURE: SYSTEMATIC REVIEWS
    Kim, S. Y.
    Bang, H. Y.
    Sul, A. R.
    VALUE IN HEALTH, 2015, 18 (07) : A401 - A401
  • [34] ST2 and Multimarker Testing in Acute Decompensated Heart Failure
    Mebazaa, Alexandre
    Di Somma, Salvatore
    Maisel, Alan S.
    Bayes-Genis, Antoni
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (07): : 38B - 43B
  • [35] Soluble ST2 and Galectin-3 in Heart Failure
    Shah, Ravi V.
    Januzzi, James L., Jr.
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (01) : 87 - +
  • [36] ST2 Pathogenetic Profile in Ambulatory Heart Failure Patients
    Bayes-Genis, Antoni
    Januzzi, James L.
    Gaggin, Hanna K.
    de Antonio, Marta
    Motiwala, Shweta R.
    Zamora, Elisabet
    Galan, Amparo
    Domingo, Mar
    Urrutia, Agustin
    Lupon, Josep
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (04) : 355 - 361
  • [37] Soluble ST2: a valuable prognostic marker in heart failure
    Sugeevan Savarimuthu
    Pavan Goel
    Amer Harky
    Heart Failure Reviews, 2022, 27 : 2155 - 2164
  • [38] Soluble ST2 in Heart Failure With Preserved Ejection Fraction
    AbouEzzeddine, Omar F.
    McKie, Paul M.
    Dunlay, Shannon M.
    Stevens, Susanna R.
    Felker, G. Michael
    Borlaug, Barry A.
    Chen, Horng H.
    Tracy, Russell P.
    Braunwald, Eugene
    Redfield, Margaret M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (02):
  • [39] Strenuous work: ST2 and renal function in heart failure
    Gaze, David C.
    BIOMARKERS IN MEDICINE, 2014, 8 (02) : 236 - 237
  • [40] ST2 in patients with severe aortic stenosis and heart failure
    Cai, Andrew
    Miyazawa, Alejandra
    Sunderland, Nicholas
    Piper, Susan E.
    Gibbs, Thomas G. J.
    Wang, Duolao
    Redding, Sadie
    Amin-Youseff, George
    Wendler, Olaf
    Byrne, Jonathan
    MacCarthy, Philip A.
    Shah, Ajay M.
    McDonagh, Theresa A.
    Dworakowski, Rafal
    CARDIOLOGY JOURNAL, 2021, 28 (01) : 129 - 135